BOSTON (AP) _ Haemonetics Corp. (HAE) on Thursday reported a fiscal fourth-quarter loss of $11 million, after reporting a profit in the same period a year earlier.
The Boston-based company said it had a loss of 22 cents per share. Earnings, adjusted for one-time gains and costs, came to 46 cents per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 67 cents per share.
The provider blood management systems for health care providers and blood collectors posted revenue of $225 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $225.2 million.
For the year, the company reported profit of $79.5 million, or $1.55 per share. Revenue was reported as $870.5 million.
Haemonetics expects full-year earnings in the range of $2.60 to $3 per share.
Haemonetics shares have dropped 50% since the beginning of the year. The stock has decreased 40% in the last 12 months.
The Associated Press